(Q43651734)

English

Adjustment of nicotine replacement therapies according to saliva cotinine concentration: the ADONIS* trial-a randomized study in smokers with medical comorbidities

scientific article published on 14 February 2011

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Adjustment of nicotine replacement therapies according to saliva cotinine concentration: the ADONIS* trial-a randomized study in smokers with medical comorbidities (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Ivan Berlin

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Nelly Jacob

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Mathieu Coudert

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Jean Perriot

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Laurette Schultz

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Nicolas Rodon

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

14 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

106

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

833-843

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Metabolism of nicotine to cotinine studied by a dual stable isotope method.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03306.X

21 January 2018

Nicotine yield from machine-smoked cigarettes and nicotine intakes in smokers: evidence from a representative population survey

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03306.X

21 January 2018

Nicotine intake and dose response when smoking reduced-nicotine content cigarettes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03306.X

21 January 2018

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03306.X

21 January 2018

Measures of abstinence in clinical trials: issues and recommendations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03306.X

21 January 2018

Validity of the 12-item French version of the Tobacco Craving Questionnaire in treatment-seeking smokers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03306.X

21 January 2018

Signs and symptoms of tobacco withdrawal.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03306.X

21 January 2018

Detecting alcoholism. The CAGE questionnaire

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03306.X

21 January 2018

Benefits and Risks of Pharmacological Smoking Cessation Therapies in Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03306.X

21 January 2018

Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03306.X

21 January 2018

Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03306.X

21 January 2018

Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03306.X

21 January 2018

Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03306.X

21 January 2018

Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03306.X

21 January 2018

Real-world efficacy of prescription and over-the-counter nicotine replacement therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03306.X

21 January 2018

Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03306.X

21 January 2018

Regulation of nicotine replacement therapies (NRT): a critique of current practice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03306.X

21 January 2018

Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03306.X

21 January 2018

Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03306.X

21 January 2018

Are there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03306.X

21 January 2018

Sex differences in long-term smoking cessation rates due to nicotine patch

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03306.X

21 January 2018

Assessing the outcomes of prolonged cessation-induction and aid-to-cessation trials: floating prolonged abstinence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03306.X

21 January 2018

Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03306.X

21 January 2018

The Safety of Transdermal Nicotine as an Aid to Smoking Cessation in Patients with Cardiac Disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2010.03306.X

21 January 2018

Identifiers

10.1111/J.1360-0443.2010.03306.X

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43651734&oldid=2102328927"